Lisanti Capital Growth’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-81,398
| Closed | -$3.95M | – | 111 |
|
|
2020
Q2 | $3.95M | Sell |
81,398
-6,868
| -8% | -$333K | 0.8% | 64 |
|
|
2020
Q1 | $3.73M | Sell |
88,266
-34,285
| -28% | -$1.45M | 1.23% | 28 |
|
|
2019
Q4 | $5.24M | Buy |
122,551
+15,026
| +14% | +$643K | 1.39% | 27 |
|
|
2019
Q3 | $3.87M | Buy |
107,525
+65,665
| +157% | +$2.36M | 1.26% | 31 |
|
|
2019
Q2 | $1.12M | Sell |
41,860
-64,675
| -61% | -$1.73M | 0.36% | 81 |
|
|
2019
Q1 | $2.86M | Buy |
+106,535
| New | +$2.86M | 1.01% | 39 |
|
|
2016
Q3 | – | Sell |
-12,355
| Closed | -$401K | – | 95 |
|
|
2016
Q2 | $401K | Sell |
12,355
-25,215
| -67% | -$818K | 0.6% | 75 |
|
|
2016
Q1 | $1.05M | Buy |
37,570
+23,277
| +163% | +$651K | 1.24% | 32 |
|
|
2015
Q4 | $510K | Sell |
14,293
-4,892
| -25% | -$175K | 0.54% | 75 |
|
|
2015
Q3 | $634K | Sell |
19,185
-25,291
| -57% | -$836K | 0.57% | 72 |
|
|
2015
Q2 | $1.86M | Sell |
44,476
-16,642
| -27% | -$697K | 1.34% | 35 |
|
|
2015
Q1 | $1.99M | Sell |
61,118
-68,673
| -53% | -$2.24M | 1.14% | 39 |
|
|
2014
Q4 | $4.12M | Buy |
129,791
+26,241
| +25% | +$833K | 2.06% | 4 |
|
|
2014
Q3 | $2.56M | Buy |
+103,550
| New | +$2.56M | 1.29% | 32 |
|
|
2014
Q1 | – | Sell |
-38,760
| Closed | -$969K | – | 95 |
|
|
2013
Q4 | $969K | Sell |
38,760
-27,595
| -42% | -$690K | 0.41% | 88 |
|
|
2013
Q3 | $1.82M | Buy |
+66,355
| New | +$1.82M | 0.83% | 54 |
|